Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05807542
What this trial is testing

Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC

Who this might be right for
Esophagus Cancer
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT05265013
What this trial is testing

ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases

Who this might be right for
Head and Neck Cancer
Rakuten Medical, Inc. 16
Testing effectiveness (Phase 2)UnknownNCT04992988
What this trial is testing

Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaToripalimabRecurrent Nasopharyngeal Squamous Cell Carcinoma
Cancer Hospital of Guangxi Medical University 40
Not applicableUnknownNCT03652142
What this trial is testing

Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCCDNA DamageDNA Double Strand Break
Attikon Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Not applicableStudy completedNCT02778191
What this trial is testing

Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Medical Center Groningen 413
Not applicableLooking for participantsNCT07054086
What this trial is testing

Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shanghai Zhongshan Hospital 30
Large-scale testing (Phase 3)Study completedNCT04543617
What this trial is testing

Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hoffmann-La Roche 760
Testing effectiveness (Phase 2)UnknownNCT06235918
What this trial is testing

Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomasResectable Head and Neck Squamous-cell Carcinoma
Xiang Lu 30
Large-scale testing (Phase 3)Looking for participantsNCT06992427
What this trial is testing

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaStage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8+2 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)WithdrawnNCT03592407
What this trial is testing

Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT02923258
What this trial is testing

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 224
Not applicableUnknownNCT04224363
What this trial is testing

Whether it is More Appropriate to Spray Lugol's Solution From Cervical Esophagus to Esophagogastric Junction

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shandong University 80
Very early researchStudy completedNCT05678348
What this trial is testing

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerCancer of the Head and Neck
Washington University School of Medicine 22
Testing effectiveness (Phase 2)Study completedNCT00589667
What this trial is testing

A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT04189107
What this trial is testing

Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS

Who this might be right for
AnalgesiaSurgeryCancer of Head and Neck+4 more
Rigshospitalet, Denmark 18
Not applicableUnknownNCT06805071
What this trial is testing

Decisional Regret in Open Partial Horizontal Laryngectomy

Who this might be right for
Laryngeal Squamous Cell Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 100
Not applicableStudy completedNCT00483821
What this trial is testing

A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 165
Testing effectiveness (Phase 2)Active Not RecruitingNCT04080804
What this trial is testing

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Dan Zandberg 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04074967
What this trial is testing

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Who this might be right for
Renal Cell CarcinomaMelanomaSolid Tumor+2 more
Dan Zandberg 70
Next Page
228